Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$323K Sell
1,862
-244
-12% -$50K 0.01% 149
2025
Q4
$539K Buy
2,106
+1,101
+110% +$289K 0.02% 127
2025
Q3
$262K Hold
1,005
0.01% 164
2025
Q2
$246K Buy
1,005
+209
+26% +$52.1K 0.01% 150
2025
Q1
$211K Sell
796
-58
-7% -$15.7K 0.01% 154
2024
Q4
$217K Hold
854
0.01% 133
2024
Q3
$270K Hold
854
0.01% 135
2024
Q2
$319K Buy
+854
New +$288K 0.01% 96
2024
Q1
Sell
-2,487
Closed -$1.14M 617
2023
Q4
$1.14M Sell
2,487
-39
-2% -$19.2K 0.04% 151
2023
Q3
$1.23M Sell
2,526
-439
-15% -$206K 0.04% 124
2023
Q2
$1.33M Sell
2,965
-102
-3% -$51.3K 0.04% 121
2023
Q1
$1.49M Sell
3,067
-476
-13% -$235K 0.05% 113
2022
Q4
$1.81M Sell
3,543
-95
-3% -$49.9K 0.06% 114
2022
Q3
$1.76M Sell
3,638
-578
-14% -$281K 0.07% 95
2022
Q2
$1.97M Buy
4,216
+1,299
+45% +$578K 0.07% 111
2022
Q1
$1.27M Buy
2,917
+1,974
+209% +$826K 0.04% 129
2021
Q4
$437K Buy
943
+221
+31% +$97.8K 0.02% 188
2021
Q3
$281K Buy
722
+159
+28% +$67.5K 0.01% 191
2021
Q2
$249K Buy
+563
New +$246K 0.01% 136
2020
Q3
Sell
-427
Closed -$166K 481
2020
Q2
$166K Sell
427
-6
-1% -$2.25K 0.01% 112
2020
Q1
$136K Buy
433
+275
+174% +$92.8K 0.01% 97
2019
Q4
$58K Buy
158
+125
+379% +$39.6K ﹤0.01% 169
2019
Q3
$8K Buy
33
+14
+74% +$3.92K ﹤0.01% 400
2019
Q2
$5K Buy
+19
New +$4.82K ﹤0.01% 496

Other funds holding HUM

Balentine LLC's HUM Position: Q1 2026 in Review

Balentine LLC reduced its Humana (HUM) stake by 12% in Q1 2026, selling an estimated $50K and leaving 1,862 shares worth $323K. The position accounts for 0.01% of the portfolio, ranked #149.

Balentine LLC first reported a position in HUM in Q2 2019 and has held it in 24 quarters since. The position peaked at $1.97M in Q2 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Balentine LLC held 1,862 shares of Humana worth $323K as of Q1 2026.
  • Balentine LLC sold 244 Humana shares in Q1 2026, an estimated $50K.
  • Humana made up 0.01% of Balentine LLC's portfolio in Q1 2026, its #149 holding.
  • Balentine LLC first reported a position in Humana in Q2 2019 and has held it in 24 quarters since.
  • Balentine LLC's Humana position peaked at $1.97M in Q2 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.